Mei Y, Ren K, Liu Y, Ma A, Xia Z, Han X
J Clin Invest. 2022; 132(17).
PMID: 35900794
PMC: 9435651.
DOI: 10.1172/JCI152673.
Yang H, Beutler B, Zhang D
Protein Cell. 2021; 13(8):559-579.
PMID: 34196950
PMC: 9232692.
DOI: 10.1007/s13238-021-00856-5.
Raundhal M, Ghosh S, Myers S, Cuoco M, Singer M, Carr S
Nat Immunol. 2021; 22(4):520-529.
PMID: 33753942
PMC: 8026551.
DOI: 10.1038/s41590-021-00895-4.
Cheng P, Eksioglu E, Chen X, Kandell W, Trinh T, Cen L
Leukemia. 2019; 33(8):2034-2046.
PMID: 30737486
PMC: 6687540.
DOI: 10.1038/s41375-019-0397-9.
Eksioglu E, Chen X, Heider K, Rueter B, McGraw K, Basiorka A
Leukemia. 2017; 31(10):2172-2180.
PMID: 28096534
PMC: 5552472.
DOI: 10.1038/leu.2017.21.
Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9.
Schneider R, Schenone M, Ferreira M, Kramann R, Joyce C, Hartigan C
Nat Med. 2016; 22(3):288-97.
PMID: 26878232
PMC: 4870050.
DOI: 10.1038/nm.4047.
Clinical utility of lenalidomide in the treatment of myelodysplastic syndromes.
Abou Zahr A, Saad Aldin E, Komrokji R, Zeidan A
J Blood Med. 2015; 6:1-16.
PMID: 25565910
PMC: 4278786.
DOI: 10.2147/JBM.S50482.
Constitutive IRF8 expression inhibits AML by activation of repressed immune response signaling.
Sharma A, Yun H, Jyotsana N, Chaturvedi A, Schwarzer A, Yung E
Leukemia. 2014; 29(1):157-68.
PMID: 24957708
DOI: 10.1038/leu.2014.162.
Efficacy and safety of lenalidomide in patients with myelodysplastic syndrome with chromosome 5q deletion.
Duong V, Komrokji R, List A
Ther Adv Hematol. 2013; 3(2):105-16.
PMID: 23556117
PMC: 3573434.
DOI: 10.1177/2040620711435659.
The 5q- syndrome: biology and treatment.
Padron E, Komrokji R, List A
Curr Treat Options Oncol. 2011; 12(4):354-68.
PMID: 21964863
DOI: 10.1007/s11864-011-0165-1.
Evidence-based genomic diagnosis characterized chromosomal and cryptic imbalances in 30 elderly patients with myelodysplastic syndrome and acute myeloid leukemia.
Bajaj R, Xu F, Xiang B, Wilcox K, Diadamo A, Kumar R
Mol Cytogenet. 2011; 4:3.
PMID: 21251322
PMC: 3031273.
DOI: 10.1186/1755-8166-4-3.
